Effect of Deoxyribonuclease in the treatment of Alzheimer’s
A 77-year-old man was diagnosed with secondary to late onset Alzheimer’s disease. Fourteen months post the diagnosis, patient began treatment with 10 mg memantine. After thirteen months of treatment, patient’s scores on MMSE and FAST were 10 and 5 respectively. Further, significant deterioration of cognitive function was observed after 3 months. His current MMSE and […]